(2012). "Insulin-pump therapy for type 1 diabetes mellitus." New England Journal of Medicine366(17): 1616-1624.Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-24.Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. NEJM 2012; 366: ...
Interim therapy with subcutaneous injection of Fiasp® may be required. Patients using continuous subcutaneous insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure. Drug Interactions Drugs That May In...
We present the case of a 29.5-year-old girl with Down's syndrome, type 1 diabetes mellitus (DMT1), autoimmune thyroiditis and celiac disease starting on insulin pump therapy. After 22-month follow-up hemoglobin A1c dropped from 9% to 6.8%, even with a lower insulin requirement and no cha...
Insulin pump therapy for type 1 diabetes 来自 ProQuest 喜欢 0 阅读量: 11 作者: Jacobs, Philip 摘要: Author information: (1)Diabetes Research Group, Division of Diabetes and Nutritional Sciences, King's College London School of Medicine and Guy's Hospital, London, United Kingdom. john.pick...
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has ...
Type-1-diabetes-mellitus, treatmentDiscusses the benefits of insulin pump therapy for pediatric patients with type 1 diabetic mellitus. Effect of the therapy on hemoglobin levels of the patients; Decline in the frequency of severe hypoglycemia episodes; Comparison between the quality of life scores ...
Alsaleh FM, Smith FJ, Thompson R, Al-Saleh MA, Taylor KMG. Insulin pump therapy: impact on the lives of children/young peo- ple with diabetes mellitus and their parents. Int J Clin Pharm. 2014;36:1023‐1030.Alsaleh FM, Smith FJ, Thompson R, et al. Insulin pump therapy: impact on...
The current goals for the therapy of children and adolescents with type 1 diabetes mellitus are to achieve as near- normal glycaemia with a minimum risk of severe hypoglycemia, to limit excessive weight gain while achieving adequate growth, to improve quality of life for both the patients and ...
The level of glycaemic control necessary to achieve optimal outcomes in subjects with type 1 diabetes mellitus typically requires intensified insulin therapy using multiple daily injections or continuous subcutaneous insulin infusion (CSII). For CSII, the insulins of choice are the rapid-acting insulin...
Because of age-related developmental and cognitive issues, children <10 years of age may not be able to wear an insulin pump safely when they are not under direct parental supervision. The purpose of this study was to determine if insulin pump therapy at nighttime only, when children are at...